Skip to Content

Intelgenx Technologies Corp IGXT

Morningstar Rating
$0.17 0.01 (2.94%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IGXT is trading at a 49% discount.
Price
$0.17
Fair Value
$4.55
Uncertainty
Extreme
1-Star Price
$2.64
5-Star Price
$9.51
Economic Moat
Rhxb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IGXT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.17
Day Range
$0.160.17
52-Week Range
$0.090.22
Bid/Ask
$0.16 / $0.18
Market Cap
$28.82 Mil
Volume/Avg
53,282 / 86,494

Key Statistics

Price/Earnings (Normalized)
Price/Sales
28.58
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
50

Valuation

Metric
IGXT
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
28.58
Price/Cash Flow
Price/Earnings
IGXT

Financial Strength

Metric
IGXT
Quick Ratio
0.36
Current Ratio
0.41
Interest Coverage
−5.13
Quick Ratio
IGXT

Profitability

Metric
IGXT
Return on Assets (Normalized)
−122.13%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−163.57%
Return on Assets
IGXT
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRBvszrxzmsjBxpv$550.4 Bil
VRTX
Vertex Pharmaceuticals IncRxbhqhgkwWzqplfk$101.7 Bil
REGN
Regeneron Pharmaceuticals IncGskmsxwmsVrkbxrv$98.1 Bil
MRNA
Moderna IncNtrygfrFmhg$38.8 Bil
ARGX
argenx SE ADRWkdmlnsMqsd$21.7 Bil
BNTX
BioNTech SE ADRLxjsfsbyqZbqb$20.8 Bil
ALNY
Alnylam Pharmaceuticals IncChbqjpszwWxkdfts$18.4 Bil
BMRN
Biomarin Pharmaceutical IncWxpzrwfzZsmgkc$17.1 Bil
RPRX
Royalty Pharma PLC Class AMcdcdsrjlZtldbfc$12.5 Bil
INCY
Incyte CorpZtmhtjyVznzmy$11.9 Bil

Sponsor Center